IngaBritt och Arne Lundbergs Forskningsstiftelse
Merchant Arne Lundberg was born in Gothenburg on December 23, 1910. In 1929, he secured a position with the company Malmsten & Bergvall, where he subsequently became a partner. In 1965, he was appointed CEO of AB Fortia, the parent company of Pharmacia AB. He also sat on a number of boards, including Adaco AB, where he was chairman, Pharmacia AB, Säfveåns AB, Återförsäkrings AB Skandia and the Gothenburg Chamber of Commerce. Arne Lundberg died in 1973.
To honour the memory of Arne Lundberg, his wife, IngaBritt Lundberg, donated the Foundation capital by deed of gift on September 28, 1982. In 1995, IngaBritt Lundberg was made an Honorary Doctor of Medicine at Sahlgrenska Academy. She died on June 6, 1999 and in her will she bequeathed further capital for the Foundation.
The Foundation has its registered office in Gothenburg.
History
Here you can download a PDF file (in Swedish) for further reading of the interesting history behind Inga Britt and Arne Lundberg Research Foundation.
The purpose of the Foundation
According to Section 3, paragraph 1 of the Foundation Statutes (PDF – in Swedish only): “The purpose of the Foundation is to promote scientific medical research, mainly dealing with cancer, renal disease and orthopaedics.”
About the Foundation’s grants
The IngaBritt and Arne Lundbergs Research Foundation provides grants for medical scientific research, including those related to cancer, kidney diseases and orthopedics. From 2026, grants will also be provided for Lung and Intestinal Diseases. The foundation prioritizes the purchase of equipment, aids and supplies.
The Lundbergs Research Foundation was founded in 1982 by IngaBritt Lundberg in memory of her husband, businessman Arne Lundberg, born in 1910 in Gothenburg, where he also worked. During the years 1983 to 2025, 642 grants have been granted, totaling 1,139 million SEK, of which 46 million SEK was granted in 2025. Some larger grants have been made, including to a kidney research laboratory and a groundbreaking project in cancer research in Lund. Research within the Gothenburg region has priority.